Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Health & MedicineOne-Off1yManifold MarketsNo KYCVerified resolution dataFairly calibratedCurrent community forecastNo 77.9%
Forecasters
14
Question type
binary
Methodology
Play-money forecasting platform
Source type
Forecast
Market data
Updated 12 hours ago
StaleFeb 21, 23, 8:23 PM UTCDec 31, 27, 10:59 PM UTC
Trends
Related Markets
Related questions for context, not a comparison of equivalent contracts.
Will FDA approve any mRNA vaccine against any type of human papillomavirus infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiAny vaccine against Alzheimer's disease to be safe and effective by the end of 2027?
FutuurWill the FDA approve a cure for Type 1 diabetes before 2033?
KalshiRules
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of any type of herpes simplex infection in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
Frequently asked questions
- What are the current odds for Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028??
- Manifold Markets prices No at 78% as of September 8, 2026.
- When does Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028? resolve?
- Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028? is scheduled to resolve on December 31, 2027.
- How is Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028? settled?
- Manifold Markets settles this market as follows: Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of any type of herpes simplex infection in the United States before January 1, 2028.
